Literature DB >> 11591121

Systemic macrophage activation in locally-induced experimental arthritis.

J Simon1, R Surber, G Kleinstäuber, P K Petrow, S Henzgen, R W Kinne, R Bräuer.   

Abstract

Local and systemic macrophage activation was examined during the course of monoarticular murine antigen-induced arthritis (AIA), induced by systemic immunization and subsequent local induction. The levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, IL-12p70, and nitric oxide (NO) were determined in joints, sera, and supernatants of peritoneal macrophages (the latter unstimulated or stimulated ex vivo with LPS/IFN-gamma). In comparison with normal mice, systemic immunization (day 0) was associated to significant rise of TNF-alpha in serum, IL-1beta in the joints, IL-6 in unstimulated macrophages and IL-12p70 in stimulated macrophages. Local induction led to a further significant increase of: (i) TNF-alpha, IL-1beta, and IL-6 in the joints; and (ii) IL-1beta, and IL-6 in sera and stimulated macrophages during acute and/or early chronic AIA (days 1 to 7). Unstimulated macrophages showed increased NO release (day 3), while stimulated macrophages significantly increased secretion of IL-12p70 (day 1). In late chronic AIA (day 21), cytokine/NO expression returned to immunization levels or below at all sites; solely IL-1beta in the joints remained significantly above normal levels. Therefore, the prevalently local AIA model is characterized by a mixture of local and systemic activation of the mononuclear phagocyte system (MPS). While systemic MPS activation preceding arthritis induction can be attributed to systemic immunization, further systemic activation during arthritis appears an integral pathogenetic component of AIA. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591121     DOI: 10.1006/jaut.2001.0534

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  21 in total

Review 1.  Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis.

Authors:  Gianfranco Ferraccioli; Luisa Bracci-Laudiero; Stefano Alivernini; Elisa Gremese; Barbara Tolusso; Fabrizio De Benedetti
Journal:  Mol Med       Date:  2010-08-02       Impact factor: 6.354

2.  Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells.

Authors:  Ulrike Baschant; Lucien Frappart; Una Rauchhaus; Lisa Bruns; Holger M Reichardt; Thomas Kamradt; Rolf Bräuer; Jan P Tuckermann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.

Authors:  Kenneth A Howard; Søren R Paludan; Mark A Behlke; Flemming Besenbacher; Bent Deleuran; Jørgen Kjems
Journal:  Mol Ther       Date:  2008-09-30       Impact factor: 11.454

4.  Loss of phosphoinositide 3-kinase gamma decreases migration and activation of phagocytes but not T cell activation in antigen-induced arthritis.

Authors:  Michael Gruen; Christina Rose; Christian König; Mieczyslaw Gajda; Reinhard Wetzker; Rolf Bräuer
Journal:  BMC Musculoskelet Disord       Date:  2010-04-07       Impact factor: 2.362

5.  Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

Authors:  Charlotte E Page; Shaun Smale; Sara M Carty; Nicholas Amos; Sarah N Lauder; Rhian M Goodfellow; Peter J Richards; Simon A Jones; Nicholas Topley; Anwen S Williams
Journal:  Arthritis Res Ther       Date:  2010-03-22       Impact factor: 5.156

6.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.

Authors:  D Pohlers; K Nissler; O Frey; J Simon; P K Petrow; R W Kinne; R Bräuer
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis.

Authors:  Dragana Odobasic; Michelle T Leech; Jin R Xue; Stephen R Holdsworth
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

9.  Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).

Authors:  Marion Hückel; Uta Schurigt; Andreas H Wagner; Renate Stöckigt; Peter K Petrow; Klaus Thoss; Mieczyslaw Gajda; Steffen Henzgen; Markus Hecker; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis.

Authors:  Yoony Y J Gent; Karin Weijers; Carla F M Molthoff; Albert D Windhorst; Marc C Huisman; Desirée E C Smith; Sumith A Kularatne; Gerrit Jansen; Philip S Low; Adriaan A Lammertsma; Conny J van der Laken
Journal:  Arthritis Res Ther       Date:  2013-03-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.